Physician profile
Jonathan Bonilla
NPI 1013177013
$154,006.99
in general payments reported to CMS, 2019-2025
45 companies · $12K in 2025
The $12K reported for 2025 was more than what 90% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,453 · 2020: $11K · 2021: $38K · 2022: $59K · 2023: $24K · 2024: $6,795 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $16K · Travel and Lodging: $8,726 · Consulting Fee: $2,640 · Education: $10.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15,796.56 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15,765.00 |
| Travel and Lodging | $8,725.71 |
| Consulting Fee | $2,640.00 |
| Education | $10.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $59,005.85 | 2020-2025 | Indigo System, Ruby Coil, Penumbra System |
| Janssen Pharmaceuticals, INC | $51,972.74 | 2019-2024 | Xarelto |
| Bard Peripheral Vascular, INC. | $10,910.18 | 2019-2025 | Rotarexs 6 F X 135 Cm, Atlas, Venovo |
| Angiodynamics, INC. | $6,195.45 | 2022-2025 | Auryon Laser System 100-120 Vac, Venacure 1470 Pro |
| Abbott Laboratories | $2,198.40 | 2019-2025 | Proclaim, Cardiomems, Diamondback Peripheral |
| Wilson Cook Medical Incorporated | $2,125.00 | 2022 | |
| Cook Incorporated | $2,125.00 | 2021 | |
| Inari Medical, INC. | $2,113.31 | 2020-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Philips North America LLC | $1,691.83 | 2019-2025 | Labosys |
| Stryker Corporation | $1,686.26 | 2025 | Limflow System, Clottriever Bold Catheter, Ct Thrombectomy System Kit |
| Cardiovascular Systems INC. | $1,609.87 | 2019-2023 | Diamondback Peripheral |
| Abiomed | $1,254.76 | 2021-2025 | Impella |
| Boston Scientific Corporation | $1,200.38 | 2019-2025 | Varithena Administration Pack, Eluvia, General - Vascular Intervention |
| Medtronic Vascular, INC. | $1,027.93 | 2019-2020 | |
| Reflow Medical INC | $960.07 | 2024-2025 |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $942.59 | 2021-2024 | Resolute Onyx, Ellipsys Vascular Access System, Onyx Frontier |
| W. L. Gore & Associates, INC. | $860.96 | 2019-2022 | |
| Shockwave Medical, INC | $831.86 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cook Medical LLC | $748.35 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $671.89 | 2019-2025 | |
| Surmodics, INC. | $640.10 | 2021-2025 | Pounce Thrombectomy, Pounce Thrombectomy System, Pounce Venous Thrombectomy System |
| Veryan Medical Incorporated | $459.16 | 2022-2025 | Biomimics 3d Vascular Stent System |
| Janssen Scientific Affairs, LLC | $392.76 | 2020-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $360.91 | 2019-2023 | Eliquis, Camzyos |
| Amgen INC. | $328.46 | 2020-2023 | Repatha |
| Merck Sharp & Dohme LLC | $262.90 | 2021-2024 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $244.10 | 2019-2025 | Lifevest |
| Cardiva Medical, INC. | $238.80 | 2019-2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Endologix LLC | $174.81 | 2024-2025 | Torus Stent Graft System, Endocross Device |
| Glaxosmithkline, LLC. | $126.23 | 2022-2023 | Trelegy Ellipta |
| Lantheus Medical Imaging, INC. | $113.49 | 2021 | |
| Siemens Medical Solutions USA, INC. | $98.08 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $87.77 | 2019-2023 | Tezspire, Farxiga |
| Pfizer INC. | $76.56 | 2023-2024 | |
| Heartflow, INC. | $59.16 | 2025 | |
| Axsome Therapeutics, INC. | $30.65 | 2023 | Sunosi |
| Terumo Medical Corporation | $25.02 | 2023 | Heartrail |
| Novo Nordisk INC | $24.85 | 2023 | Ozempic |
| Chiesi USA, INC. | $24.28 | 2024 | Kengreal |
| Becton, Dickinson and Company | $21.65 | 2024 | Venovo |
| Amarin Pharma, INC. | $21.08 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.57 | 2023 | Jardiance |
| Kiniksa Pharmaceuticals, LTD. | $16.25 | 2023 | Arcalyst |
| Impulse Dynamics (USA) INC. | $15.87 | 2023 | Optimizer |
| Jazz Pharmaceuticals INC. | $12.80 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Bonilla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.